DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
The compound database
Peptide Databasepage 6
264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.
- FDA-approved
- 90
- FDA-approved
- Awaiting FDA
- 8
- Awaiting FDA
- No lawful pathway
- 166
- No lawful pathway
- 181
C-type Natriuretic Peptide (CNP)
C-type natriuretic peptide (CNP) is a 22-amino acid member of the natriuretic peptide family that signals mainly through natriuretic peptide receptor B (NPR-B)…
Cardiovascular · Research Phase · Endogenous
No lawful pathway - 182
Urocortin 1
Urocortin 1 is a 40-amino acid peptide of the corticotropin-releasing factor (CRF) family that binds both CRF receptor 1 and CRF receptor 2, so unlike…
Cardiovascular · Investigational · Intravenous
No lawful pathway - 183
Urocortin 2
Urocortin 2 is a 38-amino acid member of the corticotropin-releasing factor family that is selective for CRF receptor 2. In the heart this receptor mediates…
Cardiovascular · Investigational · Intravenous
No lawful pathway - 184
Urocortin 3
Urocortin 3, also known as stresscopin, is a 38-amino acid peptide selective for CRF receptor 2. It produces vasodilation and increases cardiac output, and it…
Cardiovascular · Investigational · Intravenous
No lawful pathway - 185
Adrenomedullin
Adrenomedullin is a 52-amino acid peptide produced by vascular endothelial and smooth muscle cells with potent blood-pressure-lowering activity. It signals…
Cardiovascular · Investigational · Intravenous
No lawful pathway - 186
Angiotensin (1-7)
Angiotensin (1-7) is a seven-amino acid peptide of the renin-angiotensin system, generated from angiotensin II by ACE2 or from angiotensin I by endopeptidases…
Cardiovascular · Investigational · Subcutaneous injection, Intravenous, Oral
No lawful pathway - 187
Apelin-13
Apelin-13 is a 13-amino acid endogenous peptide and one of the most potent isoforms of the apelin family. It is a ligand for the APJ (apelin) receptor, a G…
Cardiovascular · Investigational · Intravenous
No lawful pathway - 188
Degarelix (Firmagon)
Degarelix is a synthetic decapeptide gonadotropin-releasing hormone (GnRH) receptor antagonist used for advanced prostate cancer, marketed as Firmagon. Unlike…
Oncology · FDA Approved · Subcutaneous injection
FDA-approved - 189
Triptorelin (Trelstar)
Triptorelin is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a long-acting agonist. After an initial stimulatory…
Oncology · FDA Approved · Intramuscular injection
FDA-approved - 190
Buserelin (Suprefact)
Buserelin is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a GnRH agonist. A single dose stimulates pituitary…
Oncology · In Clinical Trials · Subcutaneous injection, Intranasal
No lawful pathway - 191
Histrelin (Vantas)
Histrelin is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) that functions as a GnRH agonist. It is delivered by a subcutaneous…
Oncology · FDA Approved · Subcutaneous implant
FDA-approved - 192
Abarelix (Plenaxis)
Abarelix is a synthetic decapeptide that functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist. Because it blocks pituitary GnRH receptors…
Oncology · FDA Approved · Intramuscular injection
FDA-approved - 193
Elagolix (Orilissa)
Elagolix is an orally administered small-molecule, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist. While not a peptide itself, it blocks…
Oncology · FDA Approved · Oral
FDA-approved - 194
Relugolix (Orgovyx)
Relugolix is an orally active non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist. Although it is not a peptide, it acts through the same…
Oncology · FDA Approved · Oral
FDA-approved - 195
177Lu-PSMA-617 (Pluvicto)
177Lu-PSMA-617 (lutetium Lu 177 vipivotide tetraxetan) is a radioligand therapy that pairs a small urea-based peptidomimetic ligand for prostate-specific…
Oncology · FDA Approved · Intravenous
FDA-approved - 196
Somatostatin (Native)
Somatostatin is a naturally occurring cyclic tetradecapeptide hormone produced by neuroendocrine cells in the hypothalamus, pancreas, and gastrointestinal…
Oncology · In Clinical Trials · Intravenous
No lawful pathway - 197
Vapreotide
Vapreotide is a synthetic octapeptide analogue of somatostatin with a receptor-binding profile that differs from that of octreotide. Like other somatostatin…
Oncology · Investigational · Subcutaneous injection, Intravenous
No lawful pathway - 198
Vantictumab
Vantictumab (OMP-18R5) is a fully human monoclonal antibody, not a peptide, that inhibits Wnt pathway signaling by binding Frizzled receptors 1, 2, 5, 7, and…
Oncology · Investigational · Intravenous
No lawful pathway - 199
Tirbanibulin (Klisyri)
Tirbanibulin is a synthetic small-molecule (non-peptide) inhibitor of tubulin polymerization and Src kinase signaling. It is applied topically as a 1% ointment…
Oncology · FDA Approved · Topical
FDA-approved - 200
Plitidepsin (Aplidin)
Plitidepsin is a cyclic depsipeptide originally isolated from the Mediterranean tunicate Aplidium albicans. It binds the translation elongation factor eEF1A2…
Oncology · In Clinical Trials · Intravenous
No lawful pathway - 201
Melphalan Flufenamide (Pepaxto)
Melphalan flufenamide (melflufen, Pepaxto) is a first-in-class peptide-drug conjugate that links the alkylating agent melphalan to a dipeptide carrier. It…
Oncology · FDA Approved · Intravenous
FDA-approved - 202
Glucagon Receptor Antagonist Peptides
Glucagon receptor antagonist peptides are molecules designed to block the glucagon receptor and prevent glucagon-driven hepatic glucose output. Most are…
Gastrointestinal · Research Phase · Subcutaneous injection
No lawful pathway - 203
Motilin
Motilin is a 22-amino acid peptide hormone released from endocrine cells of the duodenal mucosa at roughly 100-minute intervals during fasting, and it is a key…
Gastrointestinal · Investigational · Intravenous
No lawful pathway - 204
Cholecystokinin (CCK)
Cholecystokinin (CCK) is a family of peptide hormones and neurotransmitters derived from proCCK; the main circulating forms are CCK-58, CCK-33, CCK-22, and…
Gastrointestinal · FDA Approved · Intravenous
FDA-approved - 205
Gastrin
Gastrin is a peptide hormone made mainly in antroduodenal G-cells, with gastrin-34 and gastrin-17 as the major forms in tissue and plasma. It acts on the CCK2…
Gastrointestinal · Investigational · Subcutaneous injection, Intravenous
No lawful pathway - 206
Peptide YY (PYY 3-36)
Peptide YY 3-36 is a 34-amino acid fragment of the 36-amino acid gut hormone peptide YY, which is released from intestinal L-cells after meals in proportion to…
Gastrointestinal · In Clinical Trials · Intravenous, Intranasal
No lawful pathway - 207
Ghrelin Receptor Antagonists
Ghrelin receptor antagonists are peptides, peptidomimetics, and small molecules designed to block the growth hormone secretagogue receptor (GHSR), also known…
Gastrointestinal · In Clinical Trials · Subcutaneous injection, Oral
No lawful pathway - 208
Guanylin
Guanylin is a 15-amino acid peptide hormone that activates guanylate cyclase-C (GC-C) receptors on intestinal epithelial cells. Binding raises intracellular…
Gastrointestinal · Research Phase · Endogenous peptide
No lawful pathway - 209
Uroguanylin (Dolcanatide)
Uroguanylin is a 16-amino acid peptide related to guanylin that activates guanylate cyclase-C (GC-C) receptors in the intestinal epithelium. Like guanylin, it…
Gastrointestinal · Investigational · Oral
No lawful pathway - 210
Dynorphin A
Dynorphin A is a 17-amino acid endogenous opioid peptide derived from prodynorphin that preferentially activates kappa-opioid receptors. Dynorphins are…
Pain · Investigational · Endogenous peptide
No lawful pathway - 211
Leu-Enkephalin
Leu-enkephalin is a pentapeptide (Tyr-Gly-Gly-Phe-Leu) identified in 1975 as one of the two enkephalins, natural ligands for opiate receptors. Enkephalins are…
Pain · Research Phase · Endogenous peptide
No lawful pathway - 212
Met-Enkephalin
Met-enkephalin is a pentapeptide (Tyr-Gly-Gly-Phe-Met) that differs from leu-enkephalin only in its C-terminal amino acid. Enkephalins are regarded as…
Pain · Investigational · Endogenous peptide
No lawful pathway - 213
Endomorphin-1
Endomorphin-1 is an amidated tetrapeptide (Tyr-Pro-Trp-Phe-NH2) isolated from brain in 1997 that binds the mu-opioid receptor with high affinity and about…
Pain · Research Phase · Endogenous peptide
No lawful pathway - 214
Endomorphin-2
Endomorphin-2 is an amidated tetrapeptide (Tyr-Pro-Phe-Phe-NH2) that, like endomorphin-1, is a highly selective mu-opioid receptor agonist. The two…
Pain · Research Phase · Endogenous peptide
No lawful pathway - 215
Nociceptin / Orphanin FQ
Nociceptin, also known as orphanin FQ (N/OFQ), is a 17-amino acid peptide identified in 1995 as the endogenous ligand of the opioid receptor-like ORL1…
Pain · Investigational · Endogenous peptide
No lawful pathway - 216
Conantokin-G
Conantokin-G is a 17-amino acid peptide from the venom of the cone snail Conus geographus that acts as an NMDA receptor antagonist. In cells expressing defined…
Pain · Investigational · Intrathecal, Intravenous
No lawful pathway
Index · all 264 peptides, A–Z
- 177Lu-PSMA-617 (Pluvicto)
- Abaloparatide (Tymlos)
- Abarelix (Plenaxis)
- ACE-031 (Ramatercept)
- ACTH (4-10) Analogs
- Adrenomedullin
- Afamelanotide (Scenesse)
- AHK-Cu (Copper Tripeptide-3)
- Albiglutide (Tanzeum)
- Alpha-Defensin 5
- Alpha-MSH
- Amycretin
- Anamorelin (Adlumiz)
- Angiotensin (1-7)
- Angiotensin II (Giapreza)
- AOD-9604
- Apelin-13
- Apraglutide
- ARA-290
- Argireline (Acetyl Hexapeptide-8)
- Atosiban
- Atrial Natriuretic Peptide (ANP)
- Beinaglutide
- Beta-Defensin 2
- Beta-Defensin 3
- Biopeptide CL (Palmitoyl Tripeptide-5)
- Bioregulator Peptides (Khavinson)
- Bivalirudin (Angiomax)
- BMP-2 (Bone Morphogenetic Protein-2)
- BMP-7 (Osteogenic Protein-1)
- Body Protection Compound (BPC) Variants
- Bombesin Analog Tracers
- Bortezomib (Velcade)
- BPC-157
- Brain Natriuretic Peptide (BNP)
- Bromantane-adjacent Peptides
- Bursin
- Buserelin (Suprefact)
- C-type Natriuretic Peptide (CNP)
- Cagrilintide
- CagriSema
- Calcitonin
- Calcitonin Gene-Related Peptide (CGRP)
- Capromorelin (Entyce)
- Carbetocin
- Carfilzomib (Kyprolis)
- Carperitide (h-ANP)
- Cathelicidin LL-37 Fragments
- Cerebrolysin
- Cetrorelix (Cetrotide)
- Cetrorelix (Cetrotide) Analog
- Cholecystokinin (CCK)
- Choriogonadotropin Alfa (Ovidrel)
- Chrysalin (TP508)
- CJC-1295
- Colistin (Polymyxin E)
- Collagen Tripeptide F (CTP-F)
- Conantokin-G
- Copper Peptide (Prezatide Copper Acetate)
- Corifollitropin Alfa (Elonva)
- Cortexin
- Cosyntropin (Cortrosyn)
- Cotadutide
- Dalargin
- Danuglipron
- Decorinyl (Tripeptide-10 Citrulline)
- Defensin HNP-1
- Degarelix (Firmagon)
- Deltorphin
- Dermorphin
- Desmopressin (DDAVP)
- Difelikefalin (Korsuva)
- Dihexa
- DOTATATE (Ga-68)
- DSIP (Delta Sleep-Inducing Peptide)
- Dulaglutide (Trulicity)
- Dynorphin A
- Ecnoglutide
- Efinopegdutide
- Elagolix (Orilissa)
- Eltrombopag Peptide Mimetics
- Endomorphin-1
- Endomorphin-2
- Enfuvirtide (Fuzeon)
- Enlicitide
- Epithalon (Epitalon)
- Eptifibatide (Integrilin)
- Exenatide (Byetta/Bydureon)
- Eyeseryl (Acetyl Tetrapeptide-5)
- FGL Peptide
- Follistatin-344
- Follitropin Alfa (Gonal-F)
- FOXO4-DRI
- Gadopentetate Peptide Conjugates
- Galanin
- Ganirelix
- Gastrin
- Gerontin (Pineal Gland Extract)
- GHK (Glycyl-Histidyl-Lysine)
- GHK-Cu
- Ghrelin (Native)
- Ghrelin Receptor Antagonists
- GHRH (Sermorelin 1-44)
- GHRP-1
- GHRP-2
- GHRP-6
- Glepaglutide
- Glucagon
- Glucagon Receptor Antagonist Peptides
- Gonadorelin (GnRH)
- Gonadotropin Releasing Hormone (GnRH) Agonists
- Goserelin (Zoladex)
- Gramicidin S
- Granulysin
- Guanylin
- Haloxyl (Chrysin + Palmitoyl Peptides)
- Hepcidin
- Hexarelin
- Histrelin (Vantas)
- Humanin
- Icatibant (Firazyr)
- IGF-1 DES (1-3)
- IGF-1 LR3 (Long-Arg3)
- Imuthiol (Diethyldithiocarbamate)
- Indolicidin
- Intranasal Insulin
- Ipamorelin
- Iseganan (IB-367)
- Kisspeptin
- Klotho Peptide
- KPV
- Lactoferricin
- Lanreotide (Somatuline Depot)
- Larazotide
- Leu-Enkephalin
- Leuphasyl (Pentapeptide-18)
- Leuprolide (Lupron)
- Leuprolide (Lupron) - Oncology
- Linaclotide (Linzess)
- Liraglutide (Saxenda/Victoza)
- Lixisenatide (Adlyxin)
- LL-37
- Lonapegsomatropin (Skytrofa)
- Lutetium-177 dotatate (Lutathera)
- Macimorelin (Macrilen)
- Magainin 2
- Matrikine Peptides
- Matrixyl (Palmitoyl Pentapeptide-4)
- Matrixyl 3000
- Matrixyl Synthe'6 (Palmitoyl Tripeptide-38)
- Mazdutide
- Mecasermin (Increlex)
- Melanotan II
- Melitane (Acetyl Hexapeptide-1)
- Melphalan Flufenamide (Pepaxto)
- Menotropin (Menopur)
- Met-Enkephalin
- MGF (Mechano Growth Factor)
- Mitochondrial-Targeted Peptides (MTP)
- MK-677 (Ibutamoren)
- Mod GRF 1-29 (CJC-1295 no DAC)
- Motilin
- MOTS-c
- Myristoyl Pentapeptide-17
- N-acetyl Selank Amidate
- N-acetyl Semax Amidate
- NAD+ Precursors (NMN)
- Nafarelin (Synarel)
- NAP (Davunetide)
- Nemifitide
- Nesiritide (Natrecor)
- Neuropeptide FF
- Neurotensin
- Nexagon (Gap Junction Peptide)
- Nisin
- Nociceptin / Orphanin FQ
- Obestatin
- Octreotide (Sandostatin)
- Omiganan
- OP-1 / BMP-7
- Orexin A
- Orexin B
- Orforglipron
- Osteogenic Growth Peptide (OGP)
- Oxytocin
- P21 (Peptide)
- Palmitoyl Tripeptide-1
- Palmitoylethanolamide (PEA)
- Pasireotide (Signifor)
- PEG-MGF
- Pegcetacoplan (Empaveli)
- Peginesatide (Omontys)
- Pegvisomant (Somavert)
- Pemvidutide
- Pentadeca Arginate (PDA)
- Pentagastrin
- Pentosan Polysulfate (Elmiron)
- Peptide YY (PYY 3-36)
- Pexiganan (MSI-78)
- Pinealon
- Plecanatide (Trulance)
- Plitidepsin (Aplidin)
- Polymyxin B
- Pramlintide (Symlin)
- PT-141 (Bremelanotide / Vyleesi)
- PTH (1-34) Analogs
- Relamorelin
- Relugolix (Orgovyx)
- Retatrutide
- RGD Peptide Tracers
- Rigin (Palmitoyl Tetrapeptide-7)
- Romiplostim (Nplate)
- Sclerostin Antibodies (Romosozumab)
- Secretin
- Selank
- Semaglutide (Ozempic/Wegovy)
- Semax
- Serelaxin (Relaxin-2)
- Sermorelin
- Setmelanotide (Imcivree)
- Sinapultide (KL4 Surfactant)
- Sirtuin-Activating Peptides
- SNAP-8 (Acetyl Octapeptide-3)
- Somapacitan (Sogroya)
- Somatostatin (Native)
- Somatropin (Genotropin)
- Spadin
- Splenopentin
- SS-31 (Elamipretide)
- Survodutide
- SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
- Tabimorelin
- Taspoglutide
- TB-500 (Thymosin Beta-4)
- Teduglutide (Gattex)
- Teriparatide (Forteo)
- Terlipressin
- Tesamorelin (Egrifta)
- Thrombopoietin (TPO)
- Thymalin
- Thymogen (Glutamyl-Tryptophan)
- Thymopentin (TP-5)
- Thymosin Alpha 1 (Zadaxin)
- Thymosin Beta-4 Fragment (TB4-Frag)
- Thymostimulin (TP-1)
- Thymulin
- Tirbanibulin (Klisyri)
- Tirzepatide (Mounjaro/Zepbound)
- Triptorelin (Trelstar)
- Trylagen (Tripeptide-10 Complex)
- Tuftsin
- Ularitide (Urodilatin)
- Urocortin 1
- Urocortin 2
- Urocortin 3
- Uroguanylin (Dolcanatide)
- Vantictumab
- Vapreotide
- Vasopressin (ADH)
- Vialox (Pentapeptide-3)
- Vilon (Lys-Glu)
- VIP (Vasoactive Intestinal Peptide)
- Vosoritide (Voxzogo)
- Ziconotide (Prialt)
Important Medical Disclaimer
The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.
Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.
© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.